SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUNPHARMA.BOLoading price...
Overview
Previous Close1,830.20
Open1,832.05
Ask1,830.65
Bid1,827.75
Day's Range1,814.05 - 1,850.95
52 Week Range1,376.75 - 1,960.20
PE Ratio(TTM)38.28
Market Cap₹4,39,282Cr
Volume₹1,07,869
Avg. Volume₹58,911
Face Value₹1
Dividend Yield0.85%
Performance
ABSCAGR
| YTD | 1 Month | 3 Months | 1 Year | 2 Years | 5 Years | 10 Years | |
|---|---|---|---|---|---|---|---|
| No results to display | |||||||
Profit/Loss
Important Ratios
| PARTICULARS | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Sales | ₹10,303 | ₹12,532 | ₹14,116 | ₹15,586 | ₹20,812 |
| Total Expenditure | ₹8,562 | ₹9,820 | ₹11,859 | ₹12,917 | ₹14,390 |
| Raw Materials | ₹3,925 | ₹4,429 | ₹5,287 | ₹5,834 | ₹6,292 |
| Employees | ₹1,249 | ₹1,370 | ₹1,442 | ₹2,001 | ₹2,157 |
| Selling, Administration Expenses | ₹601 | ₹682 | ₹703 | ₹1,448 | ₹1,828 |
| Power and Fuel Cost | ₹379 | ₹363 | ₹356 | ₹422 | ₹495 |
| Operating Profits | ₹1,742 | ₹2,712 | ₹2,257 | ₹2,669 | ₹6,423 |
| OPM% | 16.903% | 21.638% | 15.989% | 17.122% | 30.86% |
| Other Income | ₹1,286 | ₹1,511 | ₹192 | ₹1,197 | ₹329 |
| Depreciation | ₹553 | ₹562 | ₹1,236 | ₹1,350 | ₹1,601 |
| Interest | ₹541 | ₹408 | ₹268 | ₹388 | ₹472 |
| Profit Before Tax | ₹719 | ₹3,253 | ₹856 | ₹307 | ₹1,741 |
| Tax | -₹97 | ₹42 | ₹13 | ₹407 | ₹50 |
| Profit After Tax | ₹817 | ₹3,211 | ₹842 | -₹100 | ₹1,691 |
| Adjusted EPS | ₹3 | ₹13 | ₹4 | -₹0 | ₹7 |
| Net Profit Margin | 7.93% | 25.62% | 5.97% | -0.64% | 8.12% |
Company Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Mumbai, India
Website: https://www.sunpharma.com
MD & Chairman of the Board: Mr. Dilip Shantilal Shanghvi
Employees: 43,000
About Company:
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.